SCHEMBL30284487

SCHEMBL30284487

CCC(OC(=O)[C@H](C)N)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 3/20 0.36
SLC1A2 P43004 3/20 0.36
SLC1A1 P43005 2/20 0.36
LAP3 P28838 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLC7A5 Q01650 2/20 0.35
KLK7 P49862 1/20 0.34
LTA4H P09960 1/20 0.32
ENPEP Q07075 2/20 0.31
GABRP O00591 2/20 0.31
GABRD O14764 2/20 0.31
GABRA1 P14867 2/20 0.31
GABRB1 P18505 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA3 P34903 2/20 0.31
GABRA2 P47869 2/20 0.31
GABRB2 P47870 2/20 0.31
GABRA4 P48169 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7456354 0.87 SMN1; SMN2 (0.38) SMN1; SMN2KLK7
SCHEMBL8119374 0.84 SLC7A5 (0.46) SLC1A3SLC1A2SLC1A1LAP3SMN1; SMN2
SCHEMBL3731709 0.84 SLC7A5 (0.46) SLC1A3SLC1A2SLC1A1LAP3SMN1; SMN2
SCHEMBL3735883 0.82 LAP3 (0.40) LAP3SLC7A5
SCHEMBL3735881 0.82 LAP3 (0.40) LAP3SLC7A5
SCHEMBL6027560 0.82 LAP3 (0.40) LAP3SLC7A5
SCHEMBL16864886 0.82 LAP3 (0.50) SLC1A3SLC1A2SLC1A1LAP3SLC7A5
SCHEMBL9212588 0.81 SLC7A5 (0.53) SLC1A3SLC1A2SLC1A1LAP3SLC7A5
Alanine SCHEMBL15322894 0.81 LAP3 (0.33) SLC1A3SLC1A2SLC1A1LAP3SMN1; SMN2
SCHEMBL18668882 0.78 CA2 (0.40) SLC1A3SLC1A2SLC1A1SMN1; SMN2KLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4167966-A1 PHARMACEUTICAL GRANULATIONS OF WATER-SOLUBLE ACTIVE PHARMACEUTICAL INGREDIENTS XWPharma Ltd. (KY) 2023-04-26 EP disclosed